Epigenic Therapeutics
PrivateLast Round
Series B
Sep 7, 2025
Total Funding Raised
$112M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Epigenic Therapeutics is a biotechnology company that develops gene-silencing therapies using epigenome regulation and gene editing technology to treat chronic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Epigenic Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Epigenic Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 7, 2025 | ||||
| Series A | Aug 30, 2023 | ||||
| Seed | Aug 7, 2022 |
Key People
Founding team and executive leadership
Epigenic Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| FountainBridge Capital | Seed |
| Lapam Capital | Series B |
| Tigeryeah Capital | Seed |
| OrbiMed | Series B, Series A |
| Trinity Innovation Fund | Seed |
| 5Y Capital | Seed, Series A |
| Qiming Venture Partners | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 7, 2025
$60M round completed.
Epigenic Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Epigenic Therapeutics's valuation, stock price, and market status.